Cargando…

When to use frovatriptan in migraine?

Detalles Bibliográficos
Autor principal:	Tfelt-Hansen, Peer Carsten
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Milan 2011
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094647/ https://www.ncbi.nlm.nih.gov/pubmed/21512776 http://dx.doi.org/10.1007/s10194-011-0341-5

Ejemplares similares

Suggested randomised, controlled trial with frovatriptan
por: Tfelt-Hansen, Peer, et al.
Publicado: (2011)

When to use frovatriptan in migraine? A reply
por: Fierro, Brigida, et al.
Publicado: (2011)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Review of frovatriptan in the treatment of migraine
por: Kelman, Leslie
Publicado: (2008)

Suggested randomized, controlled trial for frovatriptan: a reply
por: Omboni, Stefano, et al.
Publicado: (2011)

A review of frovatriptan for the treatment of menstrual migraine
por: MacGregor, E Anne
Publicado: (2014)

Managing migraine by patient profile: role of frovatriptan
por: Cady, Roger K, et al.
Publicado: (2016)

Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015)

Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, Gianni, et al.
Publicado: (2014)

CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011)

Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine
por: Allais, Gianni, et al.
Publicado: (2016)

Verisimilitude (or “truthlikeness”) as an alternative to pro and cons: migraine and cluster headache mechanisms
por: Tfelt-Hansen, Peer Carsten
Publicado: (2010)

Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial
por: Tfelt-Hansen, Peer
Publicado: (2011)

EHMTI-0052. Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, G, et al.
Publicado: (2014)

Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study
por: Allais, Gianni, et al.
Publicado: (2013)

Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine
por: Guidotti, Mario, et al.
Publicado: (2007)

Permeability of dura mater: a possible link between cortical spreading depression and migraine pain? A comment
por: Tfelt-Hansen, Peer Carsten
Publicado: (2010)

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011)

Frovatriptan: A Review of Pharmacology, Pharmacokinetics and Clinical Potential in the Treatment of Menstrual Migraine
por: Balbisi, Ebrahim A
Publicado: (2006)

Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine
por: Savi, Lidia, et al.
Publicado: (2014)

Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008)

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
por: Tfelt-Hansen, Peer
Publicado: (2007)

What can be learned from the history of recurrence in migraine? A comment
por: Tfelt-Hansen, Peer
Publicado: (2009)

Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
por: Tfelt-Hansen, Peer
Publicado: (2007)

Are the current IHS guidelines for migraine drug trials being followed?
por: Hougaard, Anders, et al.
Publicado: (2010)

Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment
por: Tfelt-Hansen, Peer C.
Publicado: (2009)

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
por: Bartolini, Marco, et al.
Publicado: (2011)

Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
por: Tullo, Vincenzo, et al.
Publicado: (2010)

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
por: Savi, Lidia, et al.
Publicado: (2010)

Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study
por: Lisotto, Carlo, et al.
Publicado: (2013)

Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
por: Bartolini, M, et al.
Publicado: (2013)

Understanding clinical trials in migraine
por: Tfelt-Hansen, P.
Publicado: (2006)

Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route
por: Verma, Hitesh, et al.
Publicado: (2014)

The 5-HT(1F) receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
por: Tfelt-Hansen, Peer C., et al.
Publicado: (2012)

Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy
por: Guidotti, Mario, et al.
Publicado: (2013)

Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies
por: Allais, G, et al.
Publicado: (2013)

Does sumatriptan cross the blood–brain barrier in animals and man?
por: Tfelt-Hansen, Peer Carsten
Publicado: (2009)

Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study
por: Tullo, Vincenzo, et al.
Publicado: (2012)

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fn8c6cinbclcnogi6f069et32k